Literature DB >> 31760676

Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management.

Tony Dazhong Huang1,2, Jason Behary1,2, Amany Zekry1,2.   

Abstract

Due to the rising prevalence of obesity and type II diabetes mellitus, non-alcoholic fatty liver disease is becoming the leading cause of chronic liver disease in the Western world. In some patients, simple steatosis can result in non-alcoholic steatohepatitis which over time can lead to liver cirrhosis and its associated sequelae, including hepatocellular carcinoma. Early identification and management of patients at risk with intensive dietary and lifestyle modification are essential to prevent the development of advanced liver disease and its complications. In this review, we will discuss the epidemiology of non-alcoholic fatty liver disease, pathogenesis, diagnosis, management and surveillance strategies to offset the morbidity and mortality of this disease, as well as liver and non-liver-related complications.
© 2020 Royal Australasian College of Physicians.

Entities:  

Keywords:  hepatocellular carcinoma; liver cirrhosis; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis

Mesh:

Year:  2020        PMID: 31760676     DOI: 10.1111/imj.14709

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  38 in total

Review 1.  Advances in Magnetic Resonance Elastography of Liver.

Authors:  Jiahui Li; Sudhakar Kundapur Venkatesh; Meng Yin
Journal:  Magn Reson Imaging Clin N Am       Date:  2020-06-06       Impact factor: 2.266

2.  Upregulated SOCC and IP3R calcium channels and subsequent elevated cytoplasmic calcium signaling promote nonalcoholic fatty liver disease by inhibiting autophagy.

Authors:  Lin Zhang; Yifan Zhang; Yuanqing Jiang; Xiaobing Dou; Songtao Li; Hui Chai; Qianyu Qian; Miaojuan Wang
Journal:  Mol Cell Biochem       Date:  2021-04-17       Impact factor: 3.396

3.  UEG Week 2020 Poster Presentations.

Authors: 
Journal:  United European Gastroenterol J       Date:  2020-10       Impact factor: 4.623

Review 4.  Stem cell-based therapy for human diseases.

Authors:  Duc M Hoang; Phuong T Pham; Trung Q Bach; Anh T L Ngo; Quyen T Nguyen; Trang T K Phan; Giang H Nguyen; Phuong T T Le; Van T Hoang; Nicholas R Forsyth; Michael Heke; Liem Thanh Nguyen
Journal:  Signal Transduct Target Ther       Date:  2022-08-06

5.  Inhibition of γ-glutamyltransferase ameliorates ischaemia-reoxygenation tissue damage in rats with hepatic steatosis.

Authors:  Ryuichi Kubota; Nobuhiko Hayashi; Kaori Kinoshita; Takashi Saito; Kazuaki Ozaki; Yoshimichi Ueda; Mutsumi Tsuchishima; Mikihiro Tsutsumi; Joseph George
Journal:  Br J Pharmacol       Date:  2020-10-19       Impact factor: 8.739

Review 6.  Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety.

Authors:  Md Abdul Hannan; Md Ataur Rahman; Abdullah Al Mamun Sohag; Md Jamal Uddin; Raju Dash; Mahmudul Hasan Sikder; Md Saidur Rahman; Binod Timalsina; Yeasmin Akter Munni; Partha Protim Sarker; Mahboob Alam; Md Mohibbullah; Md Nazmul Haque; Israt Jahan; Md Tahmeed Hossain; Tania Afrin; Md Mahbubur Rahman; Md Tahjib-Ul-Arif; Sarmistha Mitra; Diyah Fatimah Oktaviani; Md Kawsar Khan; Ho Jin Choi; Il Soo Moon; Bonglee Kim
Journal:  Nutrients       Date:  2021-05-24       Impact factor: 5.717

7.  PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling.

Authors:  Ning Ma; Yi-Kang Wang; Sheng Xu; Qian-Zhi Ni; Qian-Wen Zheng; Bing Zhu; Hui-Jun Cao; Hao Jiang; Feng-Kun Zhang; Yan-Mei Yuan; Er-Bin Zhang; Tian-Wei Chen; Ji Xia; Xu-Fen Ding; Zhen-Hua Chen; Xiu-Ping Zhang; Kang Wang; Shu-Qun Cheng; Lin Qiu; Zhi-Gang Li; Yong-Chun Yu; Xiao-Fan Wang; Bin Zhou; Jing-Jing Li; Dong Xie
Journal:  Nat Commun       Date:  2021-05-24       Impact factor: 14.919

8.  ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation.

Authors:  Di Lu; Qiaoyun Xia; Zhiyu Yang; Shanjun Gao; Suofeng Sun; Xiaoying Luo; Zhen Li; Xiulei Zhang; Shuangyin Han; Xiuling Li; Mingbo Cao
Journal:  Ann Transl Med       Date:  2021-04

9.  Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease.

Authors:  Yuchang Li; Liting Chen; Lu Li; Chantal Sottas; Stephanie K Petrillo; Anthoula Lazaris; Peter Metrakos; Hangyu Wu; Yuji Ishida; Takeshi Saito; Lucy Golden-Mason; Hugo R Rosen; Jeremy J Wolff; Cristina I Silvescu; Samuel Garza; Garett Cheung; Tiffany Huang; Jinjiang Fan; Martine Culty; Bangyan Stiles; Kinji Asahina; Vassilios Papadopoulos
Journal:  iScience       Date:  2021-05-01

10.  Estimation of the Prevalence of Nonalcoholic Fatty Liver Disease in an Adult Population in Northern China Using the Data Mining Approach.

Authors:  TengFei Yang; Bo Zhao; Dongmei Pei
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-28       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.